# FY15-14: Tularemia Vaccine Protocol (NDBR Lot 4)

> **NCT03867162** · PHASE2 · WITHDRAWN · sponsor: **U.S. Army Medical Research and Development Command**

## Conditions studied

- Tularemia

## Interventions

- **BIOLOGICAL:** Live Attenuated Tularemia Vaccine

## Key facts

- **NCT ID:** NCT03867162
- **Lead sponsor:** U.S. Army Medical Research and Development Command
- **Sponsor class:** FED
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2021-06-09
- **Primary completion:** 2021-12-17
- **Final completion:** 2021-12-17
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** Sponsor terminated this protocol on Dec17, 2021; no subjects have been enrolled
- **Last updated:** 2023-08-21

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03867162

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03867162, "FY15-14: Tularemia Vaccine Protocol (NDBR Lot 4)". Retrieved via AI Analytics 2026-06-16 from https://api.ai-analytics.org/clinical/NCT03867162. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*